J. Goldman & Co LP - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 19 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2018$145,000
-74.5%
26,000
-58.2%
0.01%
-80.0%
Q4 2017$569,00062,2000.03%
Other shareholders

There were no reported owners of GALMED PHARMACEUTICALS LTD in Q1 2018.

NameSharesValueWeighting ↓
View complete list of GALMED PHARMACEUTICALS LTD shareholders